House Roll Call 100, 117th Congress · April 14, 2021

Advancing Education on Biosimilars Act

Question before the chamber: On Motion to Suspend the Rules and Pass

412 yea · 8 nayPassed9 not voting or present

Democrat214 yea · 0 nay

Republican198 yea · 8 nay

Solid = yea, faded = nay.

The measure

S. 164 ↗

Advancing Education on Biosimilars Act of 2021

Policy area: Health — assigned by Library of Congress subject specialists, not by this site.

How this vote is scored

Which tracked issues this roll call counts toward, and which way a yea vote moves a member on each. Direction is decided per issue, because one bill can push two issues opposite ways.

Health CareA yea counts toward “Expand coverage”
model(0.75): Promoting biosimilar education helps lower drug costs and broaden access to healthcare treatments.
Tagged by: policy-area:Health
Axis: Expand coverage ← → Restrict coverage

Who voted which way

Every member recorded on this roll call, with the party they sat with at the time.

Yea (412)

Nay (8)

Not voting or present (9)

Jodey C. ArringtonDid not vote
Lauren BoebertDid not vote
Kevin BradyDid not vote
Madison CawthornDid not vote
Neal P. DunnDid not vote
Frank D. LucasDid not vote
A. Donald McEachinDid not vote
Mark TakanoDid not vote
Ritchie TorresDid not vote

Vote records come from Voteview (voteview.com); bill titles and policy areas from the congress.gov API. See methodology for how the record was built.